RSM logo
JRSM

Home Current issue Browse archive Alerts About the journal Feedback
 
J R Soc Med 2004;97:26-27
doi:10.1258/jrsm.97.1.26
© 2004 Royal Society of Medicine

This Article
Right arrow Full Text (PDF)
Right arrow Send a Quick Comment
Right arrow Alert me when this article is cited
Right arrow Alert me when Quick Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Webber, A. P
Right arrow Articles by Benjamin, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
J R Soc Med 2004;97:26-27
© 2004 The Royal Society of Medicine

Wandering hemiparesis

Adam P Webber MRCP     Charlotte Benjamin MRCGP  

UCLA School of Medicine and VA Greater Los Angeles GRECC, Sepulveda, LA, USA

Correspondence to: Dr A Webber, 10982 Roebling Avenue, unit 341, Westwood, Los Angeles, California 90024, USA E-mail: drawebber{at}hotmail.com

In an older person by far the most likely cause of shortlasting hemiplegia is a transient ischaemic attack, but other possibilities must be excluded.

CASE HISTORY

A man of 79 was brought to hospital having been found collapsed on the floor. He was aphasic and unable to give a history. On examination he had a right hemiparesis with hyperactive reflexes and an extensor plantar response on that side. There was expressive dysphasia but comprehension was spared. Pupils were reactive to light and accommodation and there were no cranial nerve deficits. Carotid pulsations were normal with no bruit.

A left hemisphere CVA was diagnosed provisionally, aspirin 300 mg was prescribed, and he was admitted to the ward pending a cerebral CT scan and the results of his blood tests. One hour later the nurses contacted the admitting physician to say that the patient’s symptoms had fully resolved. Soon after that, the nurses contacted the physician to inform him that the hemiparesis had returned, but this time affecting the left side and sparing the right. The admitting team saw him again and confirmed that he now had a left-sided hemiparesis. At this stage, the blood results became available and revealed a blood glucose of 1.8 mmol/L. 100 mL 50% intravenous dextrose was given and the symptoms again resolved. In retrospect, the original resolution of symptoms had occurred after lunch on the ward. The patient, now able to give a history, confirmed that he had longstanding diabetes treated with glibenclamide 2.5 mg daily. He had taken two tablets that morning by mistake. A 10% glucose drip was continued overnight and he was discharged 24 hours later with normal glucose and no neurological deficits. The district nurse arranged for him to have his medications dosetted to avoid further drug errors.

Neither the casualty card nor the admission clerking indicated that an on-site blood glucose test had been done. A stroke proforma that requires documentation of such a test result has now been adopted.

COMMENT

Neurogenic responses to hypoglycaemia, mediated by the release of adrenalin and noradrenalin, include palpitations, tremor, anxiety, hunger, paraesthesia and sweating. Neuroglycopenic symptoms, caused by neuronal dysfunction, include behavioural changes, confusion, fatigue, fits and coma. Focal neurological signs such as hemiparesis are a rare presenting feature easily mistaken for stroke.

In normal circumstances, hypoglycaemia is reversed by counter-regulatory responses, the most important of which is glucagon release by pancreatic alpha cells. Catecholamine release has a similar effect.

Elderly patients with diabetes mellitus seem especially prone to long-lasting hypoglycaemia, perhaps because their pancreatic alpha-cell function is subnormal1 or because autonomic neuropathy results in a diminished catecholamine response.2 Also, the response to hypoglycaemic medications is more pronounced and prolonged (glibenclamide, which has a half-life of 10–16 hours, has caused hypoglycaemia for up to 60 hours in elderly patients3). Finally, elderly patients are at special risk of ‘hypoglycaemia unawareness’, missing the neurogenic signs so that the first manifestation of hypoglycaemia is neuroglycopenia, at which point they may be unable to take action.4 The mechanism for hypoglycaemic brain injury is thought to be disturbance of cerebral energy metabolism. However, for localized effects such as hemiparesis, cerebral vascular spasm due to disturbed autoregulation seems a likely contributor.5 With the new evidence favouring tight glycaemic control in type 2 diabetes mellitus,6 hypoglycaemic episodes of all kinds will become more common.

REFERENCES

  1. Gerich JE, Langlois M, Noacco C, et al. Lack of glucagon response to hypoglycemia in diabetes: Evidence for an intrinsic pancreatic alpha cell defect. Science1973; 182:171 –3[Abstract/Free Full Text]

  2. Hoeldtke RD, Boden G, Shuman CR, et al. Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med1982; 96:459 –62

  3. Sonnenblick M, Shilo S. Glibenclamide induced prolonged hypoglycaemia. Age Ageing1986; 15:185 –9[Abstract/Free Full Text]

  4. Mori S, Ito H. Hypoglycemia in the elderly. Jpn J Med 1988;27:160 –6[Medline]

  5. McCandless DW, Abel MS. Hypoglycemia and cerebral energy metabolism. In: McCandless DW, ed. Cerebral Energy Metabolism and Metabolic Encephalopathy. New York: Plenum Press,1985 : 27

  6. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet1998; 352:837 –53[CrossRef][Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
S. Hameed, J. R. Morton, A. Jaffe, P. I. Field, Y. Belessis, T. Yoong, T. Katz, and C. F. Verge
Early Glucose Abnormalities in Cystic Fibrosis Are Preceded by Poor Weight Gain
Diabetes Care, February 1, 2010; 33(2): 221 - 226.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
T. M. Kremer, R. G. Zwerdling, P. H. Michelson, and B. P. O'Sullivan
Intensive Care Management of the Patient With Cystic Fibrosis
J Intensive Care Med, May 1, 2008; 23(3): 159 - 177.
[Abstract] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Send a Quick Comment
Right arrow Alert me when this article is cited
Right arrow Alert me when Quick Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Webber, A. P
Right arrow Articles by Benjamin, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?